Dr. Giulio Giuliani
Giulio was born in Rome, Italy. He obtained his master degree in 2017 at the University of Rome Tor Vergata, Italy. His thesis was focused on the role of DNA damage response in osteogenic differentiation of skeletal muscle mesoangioblasts (MABs). Then, in the same university, he performed his PhD in the laboratory of Molecular Genetics directed by Prof. Gianni Cesareni. His research concerned heterogeneity and signaling pathways regulating the fate of skeletal muscle fibro/adipogenic progenitors (FAPs) in a mouse model of Duchenne muscular dystrophy (DMD). After obtaining his PhD in 2021, he did a postdoc on FLT3-driven acute myeloid leukemia (AML) in the laboratory of Dr. Francesca Sacco and in July 2021 he joined the laboratory of Prof. Ivan Đikić as a postdoctoral researcher to study cancer pathogenesis using CRISPR/Cas9 and targeted protein degradation (TPD).